234 related articles for article (PubMed ID: 25491470)
1. Behavioral effects of levodopa.
Beaulieu-Boire I; Lang AE
Mov Disord; 2015 Jan; 30(1):90-102. PubMed ID: 25491470
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
[TBL] [Abstract][Full Text] [Related]
3. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic dysregulation syndrome in Parkinson's disease.
Katzenschlager R
J Neurol Sci; 2011 Nov; 310(1-2):271-5. PubMed ID: 21868039
[TBL] [Abstract][Full Text] [Related]
5. Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features.
Ray Chaudhuri K; Poewe W; Brooks D
Mov Disord; 2018 Jul; 33(6):909-919. PubMed ID: 30134055
[TBL] [Abstract][Full Text] [Related]
6. Impulse control disorders and dopaminergic drugs.
Morgan JC; Iyer SS; Sethi KD
Arch Neurol; 2006 Feb; 63(2):298-9; author reply 299. PubMed ID: 16476826
[No Abstract] [Full Text] [Related]
7. Clinical spectrum of levodopa-induced complications.
Aquino CC; Fox SH
Mov Disord; 2015 Jan; 30(1):80-9. PubMed ID: 25488260
[TBL] [Abstract][Full Text] [Related]
8. Impulse control and repetitive behaviors in Parkinson's disease - are there differences in the relation to dopamine agonist treatment?
Somme JH; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
J Neurol Sci; 2014 Oct; 345(1-2):252-3. PubMed ID: 25048409
[No Abstract] [Full Text] [Related]
9. Drugs can trigger pathological gambling.
Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985369
[TBL] [Abstract][Full Text] [Related]
10. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
Merims D; Giladi N
Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
[TBL] [Abstract][Full Text] [Related]
11. Medication-related impulse control and repetitive behaviors in Parkinson disease.
Voon V; Fox SH
Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698
[TBL] [Abstract][Full Text] [Related]
12. [Impulse control behaviors associated with antiparkinsonian medications].
Depierreux-Lahaye F; Crémers J; Skawiniak E; Parmentier E; Delvaux V; Garraux G
Rev Med Liege; 2013; 68(5-6):221-5. PubMed ID: 23888568
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
14. Pathological gambling caused by drugs used to treat Parkinson disease.
Dodd ML; Klos KJ; Bower JH; Geda YE; Josephs KA; Ahlskog JE
Arch Neurol; 2005 Sep; 62(9):1377-81. PubMed ID: 16009751
[TBL] [Abstract][Full Text] [Related]
15. Medical hazards of the internet: gambling in Parkinson's disease.
Larner AJ
Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
[No Abstract] [Full Text] [Related]
16. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
Poletti M; Logi C; Lucetti C; Del Dotto P; Baldacci F; Vergallo A; Ulivi M; Del Sarto S; Rossi G; Ceravolo R; Bonuccelli U
J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
[TBL] [Abstract][Full Text] [Related]
17. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
Avanzi M; Uber E; Bonfà F
Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
[TBL] [Abstract][Full Text] [Related]
18. Treatment of levodopa-induced motor complications.
Stocchi F; Tagliati M; Olanow CW
Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
[TBL] [Abstract][Full Text] [Related]
19. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
Weintraub D; Koester J; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
Arch Neurol; 2010 May; 67(5):589-95. PubMed ID: 20457959
[TBL] [Abstract][Full Text] [Related]
20. [Impulse control disorders in Parkinson's disease].
Joutsa J; Kaasinen V
Duodecim; 2013; 129(22):2351-8. PubMed ID: 24397147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
